Form Bio

@form_bio & @PacBio have joined forces to advance #AAVdesign and analysis best practices! We've formed a new #AAV Working Group & launched an AAV Resource Hub to help unify & advance safer & more effective #genetherapies. hubs.li/Q02DzKM80

We’re heading to the 3rd International Human Gene Therapy Conference in Boston (March 23–25). Catch Jeremy Shelley on March 23 at 11:30am: “Optimizing #GeneTherapy Development Through Long-Read Sequencing.” If you’re attending, let’s connect: hubs.li/Q047zht50

In our inaugural #podcast, Michelle Chen, CEO of Form Bio, sits down with Rich Horgan, Founder & CEO of the @CureRareDisease, to share a deeply personal story that became a mission, accelerating #CellandGeneTherapy development for rare diseases. hubs.li/Q045CxPg0

Exciting publication alert! AlphaGenome, published in Nature by Google DeepMind, represents a major milestone in genomic #AI, building on nearly a decade of incremental progress toward unified, sequence-to-function modeling of regulatory biology. hubs.li/Q045q8dG0

Form Bio is headed to Nashville (Feb 19–20) for Frontiers 2026, Phase Capital’s annual summit, where our CEO will join the panel “Beyond the Hype Cycle: Practical Applications of #AI.” We'll explore where AI is delivering real biological insight today. hubs.li/Q040y7hk0

Ensuring #AAV #genomeintegrity is critical for safe, effective therapies. Join us Oct 29, 2PM EDT, as @Catalent_, @form_bio, @Solid_bio & @PacBio discuss how long-read sequencing is transforming rAAV design and development. Register: hubs.li/Q03Nh_-q0 #genetherapy

Proud to announce our partnership with Cure Rare Disease! 🌟 Already: 4.4x boost in AAV yield for a #DMD candidate. Together, we’re accelerating safer, more effective therapies for rare & ultra-rare diseases. accessnewswire.com/newsroom/en/co… #GeneTherapy #RareDisease

🌵🧬 We're headed to @alliancerm #CGMesa25, Oct 6-8! We'd love to connect and share our latest aggregate biological data validating our #AI/ML models : hubs.li/Q03L2Swm0

This week in @BioCentury, a key leadership change lands at the forefront of #genetherapy innovation: Michelle Chen has been named President & CEO of Form Bio, an #AI company advancing #geneticmedicine & #genomeengineering. hubs.li/Q03DC1wX0

🚀 We’re thrilled to welcome Michelle Chen, Ph.D. as Form Bio’s new President & CEO! With 25+ years in AI-driven drug discovery, biotech & pharma—including at @InSilicoMeds—she brings the vision to scale our #AI expertise in #geneticmedicine 👉 hubs.li/Q03D6TXf0

🎉 Big congrats to Brandi Cantarel, PhD, VP of Bioinformatics at @FormBio, for being named one of @DallasInnovates’ Top 75 #AI Innovators in North Texas! 👏 She’s pioneering AI in #genomics to accelerate breakthroughs in human health. 🧬 Read more: hubs.li/Q03ltj0y0

We’re heading to #ASGCT25! Pre-book a meeting with our team or stop by booth #1143 to learn how to improve #AAV #genetherapy development. Join us for in-booth activities featuring our partners Azenta, PacBio and Stanford University. hubs.li/Q03lkL8h0

Form Bio is the tech turning visionary science into reality. From de-extinction to cutting-edge #CGT, our tools design #CRISPR guides at scale, detect off-target edits, & predict functional impact. Let’s talk how we can support your next breakthrough. hubs.li/Q03khCRt0

The woolly mouse is what happens when visionary science meets cutting-edge #AI. At Form Bio, we’re not just powering de-extinction—we’re building tech that’s transforming #geneediting for human health. Learn more. hubs.li/Q03jCLD20

Form Bio is proud to be the tech behind Colossal’s dire wolf project, advancing large-scale comparative #genomics to analyze ancient DNA alongside genomes of related species to unlock key phenotypic traits. Learn more: hubs.ly/Q03hjsgF0

🔥Spots are filling fast—this event is on track to sell out! 🔥Join us for a half-day summit on #AAV #innovation w/ experts from @UNC, @UMass, @ask_bio, @alliancerm, @PacBio & more. hubs.li/Q039jsfQ0

🌟Newly Announced Speakers for the #AAV Innovation Summit–Mar 20 @NCBiotech. Early bird registration ends Feb 28—register now & save $100! Networking reception to follow. 🔗hubs.li/Q038rrQv0 #genetherapy

@alliancerm #CGSOTI25 at #JPM2025—The message is clear: #CGT’s evolution is reshaping healthcare, with an exciting future ahead as science, markets, and systems converge to drive greater adoption and impact. #genetherapy

@alliancerm delivered a compelling #CGSOTI25 at #JPM25, highlighting the sector's sift from early innovation to tangible, scalable market impact. And not just nationally, but globally. #genetherapy #celltherapy

@alliancerm #CGSOTI25 #JPM25 Contrary to myths of hesitancy, #biopharma companies are deeply investing in CGTs, signaling confidence in their transformative potential. #genetherapy

💡CASE STUDY: Boost #AAV Manufacturability with #AI/ML Partially filled AAV capsids are a challenge in #genetherapy. AI/ML offers a solution by simulating promoter performance, reducing risk of genome truncations during replication. Learn More: hubs.li/Q02ZzN__0